Trial record 1 of 1 for:    ECOG 2905 Myelodysplastic Syndrome
Previous Study | Return to List | Next Study

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00843882
Recruitment Status : Active, not recruiting
First Posted : February 13, 2009
Last Update Posted : March 23, 2018
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 31, 2018
  Study Completion Date : No date given